Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Non-Alcoholic Fatty Liver Disease
Related studies linked through entity extraction aliases.